Insider Shareholders with Direct Ownership of Adaptive Biotechnologies Corp (ADPT)
This section provides a comprehensive overview of the insiders with direct ownership of Adaptive Biotechnologies Corp (ADPT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Adaptive Biotechnologies Corp Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Chad M Robins
CEO and Chairman |
2,592,145 | 1,470,336 | 2,959,249 $22.5 Million | 65 |
Mar 06, 2025
Reduced 3.34%
|
|
Harlan S Robins
Chief Scientific Officer |
1,725,408 | 445,863 | 1,279,524 $9.75 Million | 89 |
Mar 05, 2025
Reduced 4.2%
|
|
Julie Rubinstein
President and COO |
1,519,691 | 919,070 | 588,249 $4.48 Million | 107 |
Mar 05, 2025
Reduced 3.2%
|
|
Tycho Peterson
Chief Financial Officer |
789,970 | 258,417 | 531,553 $4.05 Million | 9 |
Mar 05, 2024
Reduced 2.83%
|
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
541,509 | 148,786 | 392,723 $2.99 Million | 35 |
Mar 05, 2025
Reduced 0.77%
|
|
Susan Bobulsky
Chief Commercial Officer, MRD |
302,108 | 74,014 | 347,238 $2.65 Million | 10 |
Mar 05, 2025
Reduced 6.97%
|
|
Francis Lo
Chief People Officer |
421,388 | 88,542 | 332,846 $2.54 Million | 28 |
Mar 05, 2025
Reduced 3.98%
|
|
Kyle Piskel
Chief Financial Officer |
288,758 | 23,262 | 269,010 $2.05 Million | 13 |
Mar 05, 2025
Reduced 2.52%
|
|
Peter M Neupert
Director |
234,690 | 10,000 | 224,690 $1.71 Million | 9 |
Mar 10, 2025
Reduced 4.26%
|
|
Nitin Sood
Chief Commercial Officer, MRD |
296,090 | 81,282 | 214,808 $1.64 Million | 9 |
Aug 08, 2023
Reduced 4.68%
|
|
R Mark Adams
Chief Operating Officer |
197,974 | 72,613 | 175,361 $1.34 Million | 24 |
Apr 11, 2023
Reduced 1.3%
|
|
Stacy L Taylor
SVP and General Counsel |
267,866 | 129,801 | 139,365 $1.06 Million | 34 |
Aug 22, 2024
Reduced 16.19%
|
|
Katey Einterz Owen
Director |
72,629 | 0 | 72,629 $553,432 | 5 |
Mar 04, 2025
Added 17.49%
|
|
Robert Hershberg
Director |
136,690 | 67,000 | 69,690 $531,037 | 19 |
Mar 12, 2025
Reduced 43.2%
|
|
Michael J Pellini
Director |
164,690 | 95,000 | 69,690 $531,037 | 11 |
Mar 04, 2025
Added 18.09%
|
|
Michelle Renee Griffin
Director |
142,606 | 90,921 | 51,685 $393,839 | 33 |
Mar 06, 2025
Reduced 23.26%
|
|
Henning Thorsen
SVP, Commercial Operations |
29,061 | 0 | 29,061 $221,444 | 1 |
May 17, 2021
Added 50.0%
|
|
Leslie Trigg
Director |
25,907 | 0 | 25,907 $197,411 | 3 |
Mar 06, 2023
Added 36.32%
|
|
Kevin T Conroy
Director |
22,968 | 0 | 22,968 $175,016 | 3 |
Mar 06, 2023
Added 39.15%
|
|
Chad M Cohen
Chief Financial Officer |
694,979 | 674,375 | 21,604 $164,622 | 61 |
Dec 22, 2021
Reduced 31.64%
|
|
Lance Baldo
Chief Medical Officer |
108,644 | 91,473 | 17,171 $130,843 | 15 |
Mar 08, 2022
Reduced 16.32%
|
|
Nancy Louise Hill
EVP, Operations & Program Mana |
99,000 | 145,000 | 10,000 $76,200 | 6 |
Jan 19, 2021
Reduced 71.43%
|
|
Jyoti Palaniappan
SVP, Diagnostics, T-Detect |
29,765 | 20,607 | 9,158 $69,783 | 13 |
Jul 19, 2021
Reduced 6.64%
|
|
David E. Goel
Director |
1,504 | 0 | 1,504 $11,460 | 1 |
Feb 15, 2021
Added 50.0%
|
|
Eric Dobmeier
Director |
21,504 | 20,000 | 1,504 $11,460 | 5 |
Feb 14, 2021
Added 50.0%
|
|
Charles Sang
SVP, External Affairs |
50,000 | 50,000 | 0 $0 | 2 |
Dec 11, 2020
Reduced 100.0%
|